To the Editor The study by Huo and colleagues1 reported high complication rates and associated costs from procedures likely to be encountered by patients undergoing lung cancer screening using computed tomography (CT). This has been a topic of concern among clinicians and policymakers initiating such screening programs given the high false-positive rate of CT scans, the concern that real-world patients will have more comorbidities than reported in the National Lung Screening Trial, and the possibility of higher complication rates at centers less experienced with such screening programs.2 For these reasons, the study by Huo et al1 addresses important issues. However, we believe that the complication rates are overstated, which may lead to delays in implementation of screening programs.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Halliday SJ, Aboudara MC, Maldonado F. Complication Rates in a Study of Invasive Diagnostic Procedures for Lung Abnormalities. JAMA Intern Med. 2019;179(6):846–847. doi:10.1001/jamainternmed.2019.0960
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: